13F

Stock

Neurocrine Biosciences Inc

NBIX · held by 6 managers

Reported value

$31.3M

Holders

6

+1 new · −2 exited

Holders’ est. mark

−$5.62M

Price effect on 5 books still in the name

Largest holder

$20.9M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC181.6K$20.9M−$3.65MCut−$1.43M
DANSKE BANK A/S84.1K$9.69M−$1.89MCut−$9.37M
Swiss Life Asset Management Ltd3.65K$419.8K−$82KCut−$125.5K
Marex Group plc1.76K$203.2KNew
Leonteq Securities AG524$60.4K−$5.03KAdded$29.5K
Prestige Wealth Management Group LLC25$2.88K−$516Cut−$286

Who left

Positions as of Q3 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.